Biotech ETF Rises 17% in a Month Without NVIDIA
A biotech ETF posts a 17% gain in the trailing month even as NVIDIA weakens, underscoring a sector rotation that chal...
Assess tax efficiency between index funds and target-date funds, including distributions and potential tax-optimized strategies for investors.
28,288 articlesA biotech ETF posts a 17% gain in the trailing month even as NVIDIA weakens, underscoring a sector rotation that chal...
Oceaneering International has staged a striking rally, with a fund-backed bet signaling confidence in continued growt...
A major stake move in Armstrong World Industries sparked questions after earnings. This article breaks down what happ...
Dell Technologies rode a wave of AI server demand to a $33.4 billion quarterly revenue, beating expectations and lift...
Amid a regulatory push, centralized venues pull privacy assets from listings, yet GhostSwap keeps Monero and other co...
Urban air taxis are moving from concept to reality. This article explores Joby Aviation, the eVTOL pioneer, and wheth...
The VanEck PFXF ETF focuses on non-financial preferred securities, offering a ~6.7% yield. But investors must watch c...
The ITA ETF just ripped higher again, underscoring a multi-year upcycle in America’s rearmament push. Here’s what inv...
Investors often ask whether to favor Microsoft stock over Amazon stock. This guide breaks down core business strength...
Investors are debating whether the Vanguard Real Estate ETF or Treasuries offer better income and protection as rates...
IonQ stands out in the quantum race thanks to its accuracy edge. This article breaks down why ionq: quantum computing...
NVIDIA lands a major China AI chip deal, signaling a powerful push into the region’s AI buildout. Yet a 25% tariff th...